Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025:15:29-41.
doi: 10.2147/nrr.s491609. Epub 2025 Mar 24.

OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP) Invention Versus Waitlisted Group in African American Adults with Hypertension: A Randomized Control Trial Protocol

Carolyn Harmon Still  1 , Carla Harwell  2 , Cheryl Killion  1 , Abdus Sattar  3 , Satish E Viswanath  4
Affiliations

OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP) Invention Versus Waitlisted Group in African American Adults with Hypertension: A Randomized Control Trial Protocol

Carolyn Harmon Still et al. Nursing (Auckl). 2025.

Abstract

Background: Consistent adherence to prescribed hypertension treatment regimens is an important goal for persons living with hypertension, yet it remains a challenge for minority and underserved populations. Employing technology-based intervention (TBI) to support self-managing hypertension presents an opportunity to effectively control BP, and potentially have long-term effects on health outcomes.

Objective: The objective of this study is to test the efficacy of a TBI, OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP), as an approach to support hypertension self-management to improve BP, health-related quality of life (HRQOL), and long-term compliance in African Americans with hypertension.

Methods: This prospective, 2-arm randomized trial conducted in the Midwest will enroll African American older adults with hypertension, 50 years of age and older, recruited from primary clinics and community settings. Participants are allocated in a 1:1 ratio using computer-generated randomization to OPTIMA-BP intervention (n = 104) or Waitlist control group (n = 104). Participants are asked to participate in the study over a 12-month period and complete 5 study visits. Individuals in the OPTIMA-BP intervention group will receive three technology components (web-based education, medication adherence mHealth app, study provided home BP monitor), coupled with nurse counselling and communication to providers for guideline-directed treatment regimen. We will also collect data on knowledge-attitude mechanisms of self-management (hypertension knowledge, self-efficacy, perceived social support) and proximal behavioral mechanisms (antihypertension medication-taking, diet, exercise). Qualitative analyses will explore participants' experiences with self-managing hypertension using technology.

Results: Participant recruitment began in March 2022, and is currently ongoing. It is anticipated that preliminary findings appropriate for analysis will be disseminated Summer 2025. The primary endpoint is a change in BP (<130/80 mmHg) and improved HRQOL.

Conclusion: Using TBI along with standard preventive measures provides a unique opportunity to improve BP control and enhance secondary CVD prevention in this high-risk group.

Trial registration: ClinicalTrials.gov NCT05564728; https://clinicaltrials.gov/study/NCT05564728.

Keywords: African Americans; Older Adults; Self-efficacy; Tech-based intervention; hypertension; self-management.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest None declared.

Figures

Figure 1:
Figure 1:
Conceptual Framework.
Figure 1:
Figure 1:
Conceptual Framework.
Figure 2:
Figure 2:
Concert Study Diagram.
See this image and copyright information in PMC

References

    1. Center for Disease Control and Prevention. Hypertension cascade: hypertension prevalence, treatment and control estimates among us adults aged 18 years and older applying the criteria from the American College of Cardiology and American Heart Association’s 2017 Hypertension Guideline—NHANES 2017–2020. 2023. URL. https://millionhearts.hhs.gov/data-reports/hypertension-prevalence.html [accessed 2023-12-02]
    1. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation 2023. Jan 25;147(8):e93–e621 [10.1161/CIR.0000000000001123] - DOI - PubMed
    1. Whelton PK, Carey RM, Aronow WS, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension 2017. Nov 17;71(6):1269–1324 [doi:10.1161/HYP.0000000000000066] - DOI - PubMed
    1. Burke LE, Ma J, Azar KM, et al. Current science on consumer use of mobile health for cardiovascular disease prevention: a scientific statement from the American Heart Association. Circulation 2015. Aug 13;132(12):1157–1213 [doi:10.1161/CIR.0000000000000232] - DOI - PMC - PubMed
    1. Schorr EN, Gepner AD, Dolansky MA et al. Harnessing mobile health technology for secondary cardiovascular disease prevention in older adults: a scientific statement from the American Heart Association. Circ Cardiovasc Qual Outcomes 2021. Sep 1;14(5):e000103 [doi: 10.1161/HCQ.0000000000000103] - DOI - PubMed

Associated data

LinkOut - more resources